Garchinger Maier-Leibnitz-Kolloquium: Building and clinically translating new technology for cancer imaging and targeted radiation therapy

by Prof. Paul Keall (Image X Institute and University of Sydney, Australia)

Thursday 16 May 2024, 16:15 → 17:15 Europe/Berlin

Lecture Hall, ground floor (west) (LMU building, Am Coulombwall 1, campus Garching)

Radiation therapy, a medical specialty underpinned by physics, is a cornerstone of cancer treatment. Physics underpins the current and emerging technology used to image and target cancer with radiation. There are numerous examples of improved technology in radiation therapy resulting in significantly better patient outcomes. With half of the 18 million new cancer patients globally per year indicated for radiation therapy, any technological advance can have a large impact on the quality of millions of patient lives. There are many steps for new technology to be used to improve patient care. New technology starts in the discovery phase, with invention and innovation. The next steps are typically detailed computer simulations and experimental testing under clinically realistic conditions. Successful completion of simulations and experiments leads to the real-world testing of new technologies in clinical trials. Successful trials can translate to improved technology that is broadly available in clinical practice. Each of the steps from discovery to clinical practice requires increasing amounts of teamwork, effort, and funding. This presentation will discuss why innovation is important and give examples of building and clinically translating new technology for cancer imaging and targeted radiation therapy.

Hybrid access via ZOOM:
https://lmu-munich.zoom.us/j/98457332925?pwd=TWc3V1JkSHpyOTBPQVlMelhuNnZ1dz09
Meeting ID: 984 5733 2925
Passcode: 979953

kolloquium-16-05-24.pdf